Retrospective analysis of molecular biology mechanism of ABO blood group typing discrepancy among blood donors in Jinan blood station

• Published in: Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine Vol. 29; no. 1; pp. 75 - 78
• Main Authors: Yao, M.X., Hao, X., Xia, X.X., Lai, C., Diao, X.Q.
• Format: Journal Article
• Language: English
• Published: France Elsevier Masson SAS 01.02.2022
• Subjects: ABO Blood-Group System - genetics; ABO typing; Blood Donors; Blood Grouping and Crossmatching; Genotype; Humans; Molecular Biology; Retrospective Studies; Typing discrepancy; Genotype; Typing discrepancy; Blood donors; ABO typing
• ISSN: 1246-7820; 1953-8022
• DOI: 10.1016/j.tracli.2021.06.006

To accurately identify ABO blood typing in pre-transfusion testing is very important to ensure blood transfusion safely, which is a major responsibility of blood station. Eighty-one blood donors samples with ABO blood group typing discrepancy was collected among 61952 donor samples in our blood station from January 2019 to July 2020. Blood group serological method was used to detect ABO blood group. DNA Sequencing was used to determine the genotype. The antibody screening test detects antibodies other than ABO. In total, 61,952 donor samples were analysed for ABO typing discrepancies. The incidence among blood donors was 0.13% (81/61952). The most common reason of ABO typing discrepancies was due to specific antibody or non-specific agglutination (54.32%, 44/81), mainly anti-M antibody, cold autoantibody, anti-D antibody, anti-N antibody and anti-Lea antibody. The major cause of forward typing discrepancies among blood donors was ABO subgroups (25.93%, 21/81), including 10 cases of A subtype (1 case of A2, 2 cases of A3, 2 cases of Ax, 3 cases of AxB, 1 case of Ael, 1 case of Ahm), 6 cases of B subtype (2 cases of B3, 1 case of Bel, 3 cases of AB3), 2 cases of B subtype (A), 1 case of cisAB, and 2 cases of acquired B. The serum antibody was weakened in 16 cases (19.75%). The blood types should be correctly identified by combining serology with gene sequencing to ensure the safety of clinical blood transfusion, when the forward and reverse typing discrepancies among the blood donors.